California State Teachers Retirement System decreased its holdings in STAAR Surgical (NASDAQ:STAA) by 9.9% in the third quarter, HoldingsChannel reports. The firm owned 65,231 shares of the medical instruments supplier’s stock after selling 7,201 shares during the period. California State Teachers Retirement System’s holdings in STAAR Surgical were worth $812,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in STAA. Virtu KCG Holdings LLC purchased a new stake in shares of STAAR Surgical in the 2nd quarter valued at $118,000. Prudential Financial Inc. purchased a new stake in shares of STAAR Surgical in the 3rd quarter valued at $138,000. Citadel Advisors LLC purchased a new stake in shares of STAAR Surgical in the 3rd quarter valued at $172,000. Goldman Sachs Group Inc. boosted its stake in shares of STAAR Surgical by 68.1% in the 2nd quarter. Goldman Sachs Group Inc. now owns 19,073 shares of the medical instruments supplier’s stock valued at $206,000 after purchasing an additional 7,729 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. purchased a new stake in shares of STAAR Surgical in the 2nd quarter valued at $214,000. 77.80% of the stock is owned by institutional investors.

STAAR Surgical (STAA) opened at $16.10 on Wednesday. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.24 and a quick ratio of 1.72. STAAR Surgical has a 1-year low of $8.95 and a 1-year high of $17.60. The company has a market cap of $677.15, a price-to-earnings ratio of -402.50 and a beta of 1.19.

STAAR Surgical (NASDAQ:STAA) last issued its quarterly earnings data on Wednesday, November 8th. The medical instruments supplier reported $0.02 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.02. STAAR Surgical had a negative net margin of 2.47% and a negative return on equity of 3.34%. The business had revenue of $23.47 million during the quarter. sell-side analysts predict that STAAR Surgical will post -0.04 earnings per share for the current fiscal year.

STAA has been the subject of a number of recent analyst reports. Benchmark reiterated a “buy” rating and set a $21.00 price target on shares of STAAR Surgical in a report on Monday, November 20th. BidaskClub lowered shares of STAAR Surgical from a “sell” rating to a “strong sell” rating in a report on Saturday, January 6th. Canaccord Genuity upped their price target on shares of STAAR Surgical from $17.50 to $20.00 and gave the company a “buy” rating in a report on Friday, November 17th. Finally, Zacks Investment Research lowered shares of STAAR Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, October 11th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $17.67.

In other STAAR Surgical news, VP Keith Holliday sold 6,000 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $16.65, for a total value of $99,900.00. Following the completion of the transaction, the vice president now directly owns 45,969 shares in the company, valued at approximately $765,383.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.40% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2018/01/31/california-state-teachers-retirement-system-cuts-stake-in-staar-surgical-staa.html.

STAAR Surgical Profile

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical (NASDAQ:STAA).

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.